Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637777 · ClinicalTrials.gov registry record
The Human Microbiome and IVF Outcomes
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 332
- Enrollment target
NCT03637777 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 332 participants.
The verdict
NCT03637777 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 332 participants
- Enrollment target
Study Summary
Patients and partners undergoing an autologous IVF cycle will be recruited to participate in this prospective observational study investigating the microbiome and its association with IVF pregnancy outcomes. During the the controlled ovarian hyperstimulation cycle as well as the frozen embryo transfer cycle, a number of specimens will be collected for next generation sequencing of 16S rRNA to evaluate the microbiome profile of the reproductive and gastrointestinal tracts. Data on pregnancy outcomes will be collected prospectively and evaluated to identify associations with the microbiome.
Interventions
- DIAGNOSTIC_TEST 16S rRNA gene sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2022-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03637777
The ClinicalTrials.gov registry entry for NCT03637777 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 16S rRNA gene sequencing is the first listed.
NCT03637777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03637777 about?
NCT03637777 is a clinical study titled "The Human Microbiome and IVF Outcomes". Patients and partners undergoing an autologous IVF cycle will be recruited to participate in this prospective observational study investigating the microbiome and its association with IVF pregnancy outcomes. During the the controlled ovarian hyperstimulation cycle as well as the frozen embryo transf...
What is the current status of trial NCT03637777?
This trial is currently completed. The enrollment target is 332 participants. The study started on 2018-08-13. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT03637777?
The interventions under investigation include: 16S rRNA gene sequencing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03637777?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.